Showing results (571-580 of 591) with videos related to
Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigenAndrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefitJianda Yuan, Sacha Gnjatic, Hao Li, et al.Cancer Research|March 18, 2004
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumorsYurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patientsPaul Sabbatini, Takemasa Tsuji, Luis Ferran, et al.Nature|February 10, 2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingHirokazu Matsushita, Matthew D Vesely, Daniel C Koboldt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptakeAndrew M Scott, Fook-Thean Lee, Robert Jones, et al.Plos One|September 24, 2010
Frequent MAGE mutations in human melanomaOtavia L Caballero, Qi Zhao, Donata Rimoldi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
(124)I-huA33 antibody PET of colorectal cancerJorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinomaGeoffrey Chong, Fook Thean Lee, Wendie Hopkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancerAndrew M Scott, Greg Wiseman, Sydney Welt, et al.Pageof 60